The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Kkr Genetic Disorder Gp Llc since year 2005.
The trader's CIK number is 1780428.
At the time of the last reporting, Kkr Genetic Disorder Gp Llc was the 10% Owner of Bridgebio Pharma, Inc. .
(stock ticker symbol BBIO).
See this page for all insider trading activities at Bridgebio Pharma, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-07-01||BBIO||Bridgebio Pharma, Inc.||Buy||2,647,100||17.00||45,000,700|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kkr Genetic Disorder Gp Llc (10% Owner of Bridgebio Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.